Manmeet Singh Soni
Director of Finance/CFO bij SUMMIT THERAPEUTICS INC.
Vermogen: 12 M $ op 31-03-2024
Profiel
De heer Manmeet Singh Soni, CPA, is Uitvoerend VP, Chief Operating & Financial Officer bij Reata Pharmaceuticals, Inc., een Onafhankelijk Niet-Uitvoerend Bestuurder bij Arena Pharmaceuticals, Inc., een Onafhankelijk Bestuurder bij Pulse Biosciences, Inc. en een Onafhankelijk Bestuurder bij Summit Therapeutics, Inc. Hij zetelt in de Raad van Bestuur van Summit Therapeutics Ltd., Arena Pharmaceuticals, Inc., Pulse Biosciences, Inc. en Summit Therapeutics, Inc. De heer Soni was voorheen werkzaam als Senior VP, Chief Financial & Accounting Officer bij Alnylam Pharmaceuticals, Inc., als Chief Financial Officer & Treasurer bij ARIAD Pharmaceuticals, Inc., als Chief Financial Officer & Treasurer bij Pharmacyclics, Inc., als Controller & Senior Director-Finance bij ZELTIQ Aesthetics, Inc. en als Senior Manager-Life Science bij PricewaterhouseCoopers LLP. Hij zetelde ook in de raad van bestuur van Genoscience Pharma. Hij behaalde zijn bachelordiploma aan het Hansraj College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SUMMIT THERAPEUTICS INC
0.42% | 02-04-2024 | 2 976 190 ( 0.42% ) | 12 M $ | 31-03-2024 |
PULSE BIOSCIENCES, INC.
-.--% | 20-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Manmeet Singh Soni
| Bedrijven | Functie | Begin |
|---|---|---|
| PULSE BIOSCIENCES, INC. | Director/Board Member | 02-11-2017 |
| SUMMIT THERAPEUTICS INC. | Director of Finance/CFO | 02-04-2024 |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Director/Board Member | 24-12-2019 |
Eerdere bekende functies van Manmeet Singh Soni
| Bedrijven | Functie | Einde |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Director of Finance/CFO | 26-09-2023 |
| ARENA PHARMACEUTICALS | Director/Board Member | 11-06-2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Director of Finance/CFO | 12-08-2019 |
| ARIAD PHARMACEUTICALS, INC. | Director of Finance/CFO | 01-02-2017 |
Opleiding van Manmeet Singh Soni
| Hansraj College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| PULSE BIOSCIENCES, INC. | Health Technology |
| SUMMIT THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
ZELTIQ Aesthetics, Inc.
 ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology ZELTIQ Aesthetics, Inc. is a medical technology company, which focuses on developing and commercializing products. Its product, the coolsculpting system is designed to selectively reduce stubborn fat bulges. The company was founded by Mitchell E. Levinson in 2005 and is headquartered in North Chicago, IL. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
